Last reviewed · How we verify

NCT06830538

Study of the Anatomical and Functional Recovery and Quality of Life of Patients Undergoing Corneal Transplantation

Recruiting now Last updated 17 February 2025
What this trial tests

trial in Cornea Transplant in 2,000 participants. Currently enrolling.

Timeline
11 November 2023
Primary endpoint
1 February 2035
1 February 2035

Quick facts

Lead sponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment2,000
Start date11 November 2023
Primary completion1 February 2035
Estimated completion1 February 2035
Sites1 location across Italy

Conditions studied

Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna — full company profile →

Who can join

18 and older, any sex, with Cornea Transplant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluate the well-being of patients and clinicl outcomes of the cornea after transplantation

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other IRCCS Azienda Ospedaliero-Universitaria di Bologna trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06830538.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing